Biomarker Strategies Logo


BioMarker Strategies is a tissue-based cancer diagnostics company that is developing the SnapPath® live tumor cell testing platform* to improve the treatment of cancer.

Supported with funding from the National Cancer Institute, the SnapPath® platform enables the development of PathMap® profiles which help guide targeted drug treatment selection, including drug combinations.

SnapPath units are being utilized in human clinical and preclinical studies for advanced melanoma and other solid tumors. 


BioMarker Strategies
15601 Crabbs Branch Way
Rockville, MD 20855

Phone: 410-522-1008
Fax: 410-522-1009

*For Research Use Only (RUO). Not for use
in diagnostic procedures.

2014 BioMarker Strategies